Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Dialysate Temperature on Peritoneal Clearance
NCT04302649Phase 4Completed
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico
- Start
- Oct 2018
- Primary completion
- Dec 2018
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of peritoneal dialysate in end stage renal disease (ESRD) (2 arms), sponsored by Azienda Ospedaliera Universitaria Policlinico. Primary endpoint: Peritoneal creatinine clearance at 4 hours. Started Oct 2018; status: completed.
02
Drugs
peritoneal dialysate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT04302649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04302649.